Europe Medical Marijuana Market Forecast to 2028 - Regional Analysis - by Product Type, Application, and Distribution Channel

List of Tables

The Europe medical marijuana market is expected to grow from US$ 3,414.26 million in 2022 to US$ 9,703.38 million by 2028. It is estimated to register a CAGR of 19.0% from 2022 to 2028.

Increasing Approvals of Medical Marijuana Fuels Europe Medical Marijuana Market Growth

Recent initiatives related to the legality of medical marijuana in Europe have been indicative of a broader trend toward acceptance and acknowledgment of the therapeutic potential of cannabis. Germany, for instance, stands as one of the leaders in its robust medical marijuana market, having legalized it in 2017. The country has expanded the list of eligible medical conditions for cannabis treatment, witnessing a surge in patient registrations and imports of medical marijuana. France embarked on a two-year pilot program in 2021 to assess the feasibility and efficacy of medical cannabis for specific ailments, marking a notable step forward. The UK legalized medical marijuana in 2018, permitting a specialist doctor to prescribe cannabis-based products for specific medical conditions. However, access issues have prompted a government review to improve patient accessibility.

Moreover, Italy boasts an established medical cannabis program that caters to patients with various conditions, with ongoing efforts to streamline regulations and broaden access. The Netherlands, renowned for its progressive drug policies, provides access to medical marijuana through pharmacies. Also, Luxembourg announced plans to become the first European nation to fully legalize recreational cannabis use, signaling evolving attitudes toward cannabis. Greece, on the other hand, legalized medical cannabis in 2017, encouraging investments in cultivation, processing, and distribution. These developments collectively reflect the shifting landscape of medical marijuana in Europe, with an increasing number of countries recognizing its therapeutic value for patients with specific medical needs.

Europe Medical Marijuana Market Overview

The Europe medical marijuana market is divided into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Europe region holds a significant market share in the medical marijuana market. Europe occupies a significant position in the Europe medical marijuana market and is estimated to register a robust growth rate over the forecast period. The market growth in the region is attributed to the growing life science research and increasing investment in research and development.

Europe Medical Marijuana Market Revenue and Forecast to 2028 (US$ Million)

Europe Medical Marijuana Market Segmentation

The Europe medical marijuana market is segmented into product type, application, distribution channel, and country.

Based on product type, the Europe medical marijuana market is segmented into dried form and extract form. The extract form segment held a larger share of the Europe medical marijuana market in 2022.

Based on application, the Europe medical marijuana market is segmented into pain management, Tourette's, Alzheimer's disease, migraines, depression and anxiety, multiple sclerosis, cancer, and others. The pain management segment held the largest share of the Europe medical marijuana market in 2022.

Based on distribution channel, the Europe medical marijuana market is segmented into retail pharmacy, e-commerce, and others. The retail pharmacy segment held the largest share of the Europe medical marijuana market in 2022.

Based on country, the Europe medical marijuana market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe medical marijuana market in 2022.

Aphria, Inc.; Canopy Growth Corporation; GW Pharmaceuticals; Panaxia Pharmaceutical Industries Ltd.; and VIVO Cannabis Inc are some of the leading companies operating in the Europe medical marijuana market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe medical marijuana market .
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe medical marijuana market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00028770

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Medical Marijuana Market - by Product
- 1.3.2 Europe Medical Marijuana Market - by Application
- 1.3.3 Europe Medical Marijuana Market - by Distribution Channel
- 1.3.4 Europe Medical Marijuana Market - by Country

2. Europe Medical Marijuana Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Medical Marijuana Market - Market Landscape

4.1 Overview
4.2 Europe- PEST Analysis
4.3 Expert Opinion

5. Europe Medical Marijuana Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Approvals of Medical Marijuana
5.2 Market Restraints
- 5.2.1 Cultural and Social Stigma
5.3 Market Opportunities
- 5.3.1 Pharmaceutical Integration in the Medical Marijuana Market
5.4 Future Trends
- 5.4.1 Regional Trade and Collaboration in the Medical Marijuana Market
5.5 Impact Analysis

6. Medical Marijuana Market -Europe Analysis

6.1 Europe Medical Marijuana Market Revenue Forecast and Analysis

7. Europe Medical Marijuana Market Revenue and Forecast To 2028- by Product

7.1 Overview
7.2 Europe Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
7.3 Dried Form
- 7.3.1 Overview
- 7.3.2 Dried Form: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Extract Form
- 7.4.1 Overview
- 7.4.2 Extract Form: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Medical Marijuana Market Analysis - by Application

8.1 Overview
8.2 Europe Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Tourette's
- 8.4.1 Overview
- 8.4.2 Tourette's: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Alzheimer's Disease
- 8.5.1 Overview
- 8.5.2 Alzheimer's Disease: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Migraines
- 8.6.1 Overview
- 8.6.2 Migraines: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Depression and Anxiety
- 8.7.1 Overview
- 8.7.2 Depression and Anxiety: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Multiple Sclerosis
- 8.8.1 Overview
- 8.8.2 Multiple Sclerosis: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.9 Cancer
- 8.9.1 Overview
- 8.9.2 Cancer: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.10 Others
- 8.10.1 Overview
- 8.10.2 Others: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Medical Marijuana Market - by Distribution Channel

9.1 Overview
9.2 Europe Medical Marijuana Market , by Distribution Channel (2021 and 2028)
9.3 Retail Pharmacy
- 9.3.1 Overview
- 9.3.2 Retail Pharmacy: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
9.4 E-Commerce
- 9.4.1 Overview
- 9.4.2 E-commerce: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Medical Marijuana Market Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 Europe Medical Marijuana Market , by Country, 2021 & 2028 (%)
  - 10.1.1.1 Germany: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Germany: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.2 Germany: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 Germany: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.4 Germany: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.2 UK: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 UK: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.2 UK: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 UK: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.4 UK: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.3 France: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 France: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.2 France: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 France: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.4 France: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.4 Italy: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.1 Italy: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.2 Italy: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.3 Italy: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.4.4 Italy: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.5 Spain: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.1 Spain: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.2 Spain: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.3 Spain: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.5.4 Spain: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.6 Rest of Europe: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.1 Rest of Europe: Europe Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.2 Rest of Europe: Europe Medical Marijuana Market , by Product- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.3 Rest of Europe: Europe Medical Marijuana Market , by Application - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.6.4 Rest of Europe: Europe Medical Marijuana Market , by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)

11. Europe Medical Marijuana Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Europe Medical Marijuana Market (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 VIVO Cannabis Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Panaxia Pharmaceutical Industries Ltd.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Aphria, Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Canopy Growth Corporation
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 GW Pharmaceuticals
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms for Europe Medical Marijuana Market